Blood type and outcomes in patients with COVID-19

Rothan HA, Byrareddy SN (2020) The epidemiology and pathogenesis of coronavirus disease (COVID-19) outbreak. J Autoimmun 109:102433

Ahn DG, Shin HJ, Kim MH, Lee S, Kim HS, Myoung J, Kim BT, Kim SJ (2020) Current status of epidemiology, diagnosis, therapeutics, and vaccines for novel coronavirus disease 2019 (COVID-19). J Microbiol Biotechnol 30(3):313–324

Shi Y, Yu X, Zhao H, Wang H, Zhao R, Sheng J (2020) Host susceptibility to severe COVID-19 and establishment of a host risk score: findings of 487 cases outside Wuhan. Crit Care 24(1):108

Li B, Yang J, Zhao F, Zhi L, Wang X, Liu L, Bi Z, Zhao Y (2020) Prevalence and impact of cardiovascular metabolic diseases on COVID-19 in China. Clin Res Cardiol 109(5):531–538

von der Thüsen J, van der Eerden M (2020) Histopathology and genetic susceptibility in COVID-19 pneumonia. Eur J Clin Invest. https://doi.org/10.1111/eci.13259

Tian S, Hu N, Lou J, Chen K, Kang X, Xiang Z et al (2020) Characteristics of COVID-19 infection in Beijing. J Inf Secur 80(4):401–406

Loscertales MP, Owens S, O'Donnell J, Bunn J, Bosch-Capblanch X, Brabin BJ (2007) ABO blood group phenotypes and plasmodium falciparum malaria: unlocking a pivotal mechanism. Adv Parasitol 65:1–50

Meng J, Xiao G, Zhang J, He X, Ou M, Bi J, Yang R, di W, Wang Z, Li Z, Gao H, Liu L, Zhang G (2020) Renin-angiotensin system inhibitors improve the clinical outcomes of COVID-19 patients with hypertension. Emerg Microbes Infect 9(1):757–760

Hussain A, Bhowmik B, do Vale Moreira NC (2020) COVID-19 and diabetes: knowledge in progress. Diabetes Res Clin Pract 162:108142

Guo W, Li M, Dong Y, et al (2020) Diabetes is a risk factor for the progression and prognosis of COVID-19 [published online ahead of print, 2020 Mar 31]. Diabetes Metab Res Rev. https://doi.org/10.1002/dmrr.3319

Zhao Q, Meng M, Kumar R, et al (2020) The impact of COPD and smoking history on the severity of COVID-19: A systemic review and meta-analysis. J Med Virol. https://doi.org/10.1002/jmv.25889

Leung JM, Yang CX, Tam A, Shaipanich T, Hackett TL, Singhera GK, Dorscheid DR, Sin DD (2020) ACE-2 expression in the small airway epithelia of smokers and COPD patients: implications for COVID-19. Eur Respir J 55:2000688

Zhao J, Yang Y, Huang H, Li D, Gu D, Lu X, Zhang Z, Liu L, Liu T, Liu Y, He Y, Sun B, Wei M, Yang G, Wang X, Zhang L, Zhou X, Xing M, Wang PG (2020) Relationship between the ABO blood group and the COVID-19 susceptibility. medRxiv. https://doi.org/10.1101/2020.03.11.20031096

Zietz M, Tatonetti N (2020) Testing the association between blood type and COVID-19 infection, intubation and death. medRxiv Preprint. https://doi.org/10.1101/2020040820058073

Batool Z, Durrani SH, Tariq S (2017) Association of abo and Rh blood group types to hepatitis B, hepatitis C, Hiv and syphilis infection, a five year' experience in healthy blood donors in a tertiary care hospital. J Ayub Med Coll Abbottabad 29(1):90–92

Lindesmith L, Moe C, Marionneau S, Ruvoen N, Jiang X, Lindblad L, Stewart P, LePendu J, Baric R (2003) Human susceptibility and resistance to Norwalk virus infection. Nat Med 9(5):548–553

Cheng Y, Cheng G, Chui CH, Lau FY, Chan PK, Ng MH, Sung JJ, Wong RS (2005) ABO blood group and susceptibility to severe acute respiratory syndrome. Jama. 293(12):1450–1451

Liumbruno GM, Franchini M (2013) Beyond immunohaematology: the role of the ABO blood group in human diseases. Blood Transfus 11(4):491–499

Harris JB, LaRocque RC (2016) Cholera and ABO blood group: understanding an ancient association. Am J Trop Med Hyg 95(2):263–264

Liu J, Zhang S, Wang Q, Shen H, Zhang Y, Liu M (2017) Frequencies and ethnic distribution of ABO and RhD blood groups in China: a population-based cross-sectional study. BMJ Open 7(12):e018476